Cantor Fitzgerald Weighs in on National Health Investors, Inc.’s FY2017 Earnings (NHI)
National Health Investors, Inc. (NYSE:NHI) – Research analysts at Cantor Fitzgerald issued their FY2017 earnings estimates for shares of National Health Investors in a research note issued to investors on Tuesday. Cantor Fitzgerald analyst J. France forecasts that the real estate investment trust will earn $5.23 per share for the year. Cantor Fitzgerald also issued estimates for National Health Investors’ FY2018 earnings at $5.46 EPS.
National Health Investors (NYSE:NHI) last announced its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the consensus estimate of $1.29 by $0.36. The business had revenue of $69.84 million for the quarter, compared to the consensus estimate of $67.68 million. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The firm’s revenue was up 14.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.22 EPS.
Other research analysts also recently issued research reports about the company. BidaskClub raised National Health Investors from a “hold” rating to a “buy” rating in a research note on Thursday, June 29th. Stifel Nicolaus upped their price objective on shares of National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. Zacks Investment Research upgraded shares of National Health Investors from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research report on Wednesday, May 10th. Finally, ValuEngine cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $81.40.
National Health Investors (NYSE:NHI) opened at 80.10 on Thursday. The firm has a market capitalization of $3.28 billion, a PE ratio of 20.57 and a beta of 0.56. National Health Investors has a 12 month low of $66.31 and a 12 month high of $82.11. The stock’s 50 day moving average price is $77.93 and its 200 day moving average price is $75.70.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, September 29th will be given a $0.95 dividend. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.74%. The ex-dividend date of this dividend is Thursday, September 28th. National Health Investors’s dividend payout ratio is currently 97.69%.
In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the completion of the sale, the insider now owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a filing with the SEC, which is available through this link. 5.19% of the stock is owned by corporate insiders.
Several institutional investors and hedge funds have recently added to or reduced their stakes in NHI. Carroll Financial Associates Inc. bought a new stake in shares of National Health Investors in the 2nd quarter valued at $158,000. Quantbot Technologies LP bought a new stake in shares of National Health Investors in the 1st quarter valued at $201,000. Yorktown Management & Research Co Inc bought a new stake in shares of National Health Investors in the 2nd quarter valued at $214,000. Allegis Investment Advisors LLC bought a new stake in shares of National Health Investors in the 2nd quarter valued at $216,000. Finally, Daiwa Securities Group Inc. increased its position in shares of National Health Investors by 1.7% in the 1st quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock valued at $232,000 after buying an additional 55 shares in the last quarter. Institutional investors and hedge funds own 70.58% of the company’s stock.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.